166 related articles for article (PubMed ID: 15604250)
21. A missense mutation in the APC tumor suppressor gene disrupts an ASF/SF2 splicing enhancer motif and causes pathogenic skipping of exon 14.
Gonçalves V; Theisen P; Antunes O; Medeira A; Ramos JS; Jordan P; Isidro G
Mutat Res; 2009 Mar; 662(1-2):33-6. PubMed ID: 19111562
[TBL] [Abstract][Full Text] [Related]
22. SR proteins ASF/SF2 and SRp55 participate in tissue factor biosynthesis in human monocytic cells.
Tardos JG; Eisenreich A; Deikus G; Bechhofer DH; Chandradas S; Zafar U; Rauch U; Bogdanov VY
J Thromb Haemost; 2008 May; 6(5):877-84. PubMed ID: 18315555
[TBL] [Abstract][Full Text] [Related]
23. Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA.
Kondo S; Yamamoto N; Murakami T; Okumura M; Mayeda A; Imaizumi K
Genes Cells; 2004 Feb; 9(2):121-30. PubMed ID: 15009090
[TBL] [Abstract][Full Text] [Related]
24. Serine/arginine-rich protein-dependent suppression of exon skipping by exonic splicing enhancers.
Ibrahim EC; Schaal TD; Hertel KJ; Reed R; Maniatis T
Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5002-7. PubMed ID: 15753297
[TBL] [Abstract][Full Text] [Related]
25. Estrogen alters the splicing of type 1 corticotropin-releasing hormone receptor in breast cancer cells.
Lal S; Allan A; Markovic D; Walker R; Macartney J; Europe-Finner N; Tyson-Capper A; Grammatopoulos DK
Sci Signal; 2013 Jul; 6(282):ra53. PubMed ID: 23821771
[TBL] [Abstract][Full Text] [Related]
26. Splicing factor polymorphisms, the control of VEGF isoforms and association with angiogenic eye disease.
Carter JG; Cherry J; Williams K; Turner S; Bates DO; Churchill AJ
Curr Eye Res; 2011 Apr; 36(4):328-35. PubMed ID: 21309690
[TBL] [Abstract][Full Text] [Related]
27. Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3.
Tranell A; Fenyö EM; Schwartz S
J Biol Chem; 2010 Oct; 285(41):31537-47. PubMed ID: 20685659
[TBL] [Abstract][Full Text] [Related]
28. A stem structure in fibroblast growth factor receptor 2 transcripts mediates cell-type-specific splicing by approximating intronic control elements.
Baraniak AP; Lasda EL; Wagner EJ; Garcia-Blanco MA
Mol Cell Biol; 2003 Dec; 23(24):9327-37. PubMed ID: 14645542
[TBL] [Abstract][Full Text] [Related]
29. A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer.
Ramchatesingh J; Zahler AM; Neugebauer KM; Roth MB; Cooper TA
Mol Cell Biol; 1995 Sep; 15(9):4898-907. PubMed ID: 7651409
[TBL] [Abstract][Full Text] [Related]
30. Splicing of a myosin phosphatase targeting subunit 1 alternative exon is regulated by intronic cis-elements and a novel bipartite exonic enhancer/silencer element.
Dirksen WP; Mohamed SA; Fisher SA
J Biol Chem; 2003 Mar; 278(11):9722-32. PubMed ID: 12509424
[TBL] [Abstract][Full Text] [Related]
31. A Non-sequence-specific double-stranded RNA structural element regulates splicing of two mutually exclusive exons of fibroblast growth factor receptor 2 (FGFR2).
Muh SJ; Hovhannisyan RH; Carstens RP
J Biol Chem; 2002 Dec; 277(51):50143-54. PubMed ID: 12393912
[TBL] [Abstract][Full Text] [Related]
32. Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene.
Ghigna C; Giordano S; Shen H; Benvenuto F; Castiglioni F; Comoglio PM; Green MR; Riva S; Biamonti G
Mol Cell; 2005 Dec; 20(6):881-90. PubMed ID: 16364913
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors.
Jin W; McCutcheon IE; Fuller GN; Huang ES; Cote GJ
Cancer Res; 2000 Mar; 60(5):1221-4. PubMed ID: 10728679
[TBL] [Abstract][Full Text] [Related]
34. The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.
Homolova K; Zavadakova P; Doktor TK; Schroeder LD; Kozich V; Andresen BS
Hum Mutat; 2010 Apr; 31(4):437-44. PubMed ID: 20120036
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of splicing by serine-arginine rich protein 55 (SRp55) causes the appearance of partially spliced HIV-1 mRNAs in the cytoplasm.
Tranell A; Tingsborg S; Fenyö EM; Schwartz S
Virus Res; 2011 Apr; 157(1):82-91. PubMed ID: 21345357
[TBL] [Abstract][Full Text] [Related]
36. Distribution of SR protein exonic splicing enhancer motifs in human protein-coding genes.
Wang J; Smith PJ; Krainer AR; Zhang MQ
Nucleic Acids Res; 2005; 33(16):5053-62. PubMed ID: 16147989
[TBL] [Abstract][Full Text] [Related]
37. RNA folding affects the recruitment of SR proteins by mouse and human polypurinic enhancer elements in the fibronectin EDA exon.
Buratti E; Muro AF; Giombi M; Gherbassi D; Iaconcig A; Baralle FE
Mol Cell Biol; 2004 Feb; 24(3):1387-400. PubMed ID: 14729981
[TBL] [Abstract][Full Text] [Related]
38. Exon and intron sequences, respectively, repress and activate splicing of a fibroblast growth factor receptor 2 alternative exon.
Del Gatto F; Breathnach R
Mol Cell Biol; 1995 Sep; 15(9):4825-34. PubMed ID: 7651400
[TBL] [Abstract][Full Text] [Related]
39. A strong exonic splicing enhancer in dystrophin exon 19 achieve proper splicing without an upstream polypyrimidine tract.
Habara Y; Doshita M; Hirozawa S; Yokono Y; Yagi M; Takeshima Y; Matsuo M
J Biochem; 2008 Mar; 143(3):303-10. PubMed ID: 18039686
[TBL] [Abstract][Full Text] [Related]
40. Multiple sequence variants of BRCA2 exon 7 alter splicing regulation.
Gaildrat P; Krieger S; Di Giacomo D; Abdat J; Révillion F; Caputo S; Vaur D; Jamard E; Bohers E; Ledemeney D; Peyrat JP; Houdayer C; Rouleau E; Lidereau R; Frébourg T; Hardouin A; Tosi M; Martins A
J Med Genet; 2012 Oct; 49(10):609-17. PubMed ID: 22962691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
